Autolus Therapeutics PLC
NASDAQ:AUTL

Watchlist Manager
Autolus Therapeutics PLC Logo
Autolus Therapeutics PLC
NASDAQ:AUTL
Watchlist
Price: 2.05 USD -0.49% Market Closed
Market Cap: 545.6m USD

Intrinsic Value

AUTL's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one AUTL stock under the Base Case scenario is 7.24 USD. Compared to the current market price of 2.05 USD, Autolus Therapeutics PLC is Undervalued by 72%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AUTL Intrinsic Value
7.24 USD
Undervaluation 72%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Autolus Therapeutics PLC

Valuation History Unavailable

Historical valuation for AUTL cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare AUTL to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AUTL?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Autolus Therapeutics PLC
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Autolus Therapeutics PLC

Current Assets 615.8m
Cash & Short-Term Investments 516.6m
Receivables 65.3m
Other Current Assets 33.9m
Non-Current Assets 130.6m
PP&E 114.2m
Intangibles 12.5m
Other Non-Current Assets 3.9m
Efficiency

Free Cash Flow Analysis
Autolus Therapeutics PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Autolus Therapeutics PLC

Revenue
9m USD
Cost of Revenue
-29.3m USD
Gross Profit
-20.3m USD
Operating Expenses
-188.4m USD
Operating Income
-208.8m USD
Other Expenses
28.9m USD
Net Income
-179.9m USD
Fundamental Scores

AUTL Profitability Score
Profitability Due Diligence

Autolus Therapeutics PLC's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
ROIC is Increasing
ROE is Increasing
27/100
Profitability
Score

Autolus Therapeutics PLC's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

AUTL Solvency Score
Solvency Due Diligence

Autolus Therapeutics PLC's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Low D/E
54/100
Solvency
Score

Autolus Therapeutics PLC's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AUTL Price Targets Summary
Autolus Therapeutics PLC

Wall Street analysts forecast AUTL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AUTL is 9.86 USD with a low forecast of 5.76 USD and a high forecast of 13.65 USD.

Lowest
Price Target
5.76 USD
181% Upside
Average
Price Target
9.86 USD
381% Upside
Highest
Price Target
13.65 USD
566% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Autolus Therapeutics PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for AUTL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

AUTL News

What is the Intrinsic Value of one AUTL stock?

The intrinsic value of one AUTL stock under the Base Case scenario is 7.24 USD.

Is AUTL stock undervalued or overvalued?

Compared to the current market price of 2.05 USD, Autolus Therapeutics PLC is Undervalued by 72%.

Back to Top